feed,title,long_url,short_url
RS,Repositioning of FDA-approved anti-cancer drugs for fatal blast crisis CML by integrated high-throughput genomic and artificial intelligence-based drug discovery analyses of pan-leukemic genetic abnormalities: Implications in post-COVID-19 era,https://www.researchsquare.com/article/rs-6071747/latest,https://da.gd/HoEoq
